Perfil
Elaine Chiquette served as the Chief Scientific Officer at Gelesis, Inc. from 2017 to 2022, and at Gelesis Holdings, Inc. from 2022 to 2023.
Prior to her work at Gelesis, she earned an undergraduate degree from Université Laval and a doctorate from the University of Texas Health Science Center At San Antonio.
Antiguos cargos conocidos de Elaine Chiquette.
| Empresas | Cargo | Fin |
|---|---|---|
| GELESIS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 30/10/2023 |
| GELESIS INC | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Formación de Elaine Chiquette.
| Université Laval | Undergraduate Degree |
| University of Texas Health Science Center At San Antonio | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GELESIS HOLDINGS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Elaine Chiquette
